Sign in Create account

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

Index Funds › Index Funds Direct plan Growth SEBI riskometer: Very High
33/100
Weak · Tradinity score
₹11.5235
-0.3123 (-2.64%)
NAV on 1 Oct 2026
Compare Download NAV history Sign in to save, track and set alerts

NAV history

Returns as of 1 Oct 2026

Up to one year: absolute. Longer: annualised. Category = median of Index Funds direct-plan Growth funds.

PeriodThis fundCategory medianRank in category
1 month -2.71% -5.37% —
3 months +1.73% -4.10% —
6 months +19.88% +3.59% —
1 year +14.71% +1.93% #9 of 318 Top 3%
3 years — +7.42% —
5 years — +6.41% —
10 years — +10.93% —
Since launch of NAV data+7.28%——

NAV high and low

WindowHighLow
1 month12.041911.5235
3 months12.041911.3279
6 months12.04199.5411
1 year12.04199.4271

A period is a dash when the fund has not existed that long or its NAV history has a hole at the start date — never a partial figure.

Calendar-year returns

202020212022202320242025YTD
This fund—————-2.98%+14.14%
Category median+15.51%+25.21%+3.61%+21.04%+9.93%+7.90%-2.53%

Tradinity fund score

Twenty checks of five points each: performance, portfolio, operations, and risk against reward. Only checks we have data for are counted.

33/100
Weak · based on 9 of 20 checks
Performance5/5
  • ✓ Ranks in the top quarter of its category over 1 year
  • – Ranks in the top quarter of its category over 3 years
  • – Ranks in the top quarter of its category over 5 years
  • – Loses less than its reference index on the index's down days
  • – Keeps pace with its reference index on the index's up days
Portfolio5/20
  • ✗ Largest holding is 10% of the fund or less (largest holding 12.9%)
  • ✗ Top ten holdings are 50% of the fund or less (top ten 54.6%)
  • ✓ Holds at least 20 stocks (126 holdings)
  • – No single sector is more than 35% of the fund (diversified equity categories)
  • ✗ Portfolio P/E is at or below the category median (portfolio P/E 57.1)
Operations5/20
  • ✗ Has a track record of at least 5 years (2.1 years of NAV history)
  • ✗ Has a track record of at least 10 years
  • ✓ Expense ratio is at or below the category median (expense ratio 0.36%)
  • ✗ Fund size is above the category median (AUM Rs 10 crore)
  • – Lead manager has run the fund for 3 years or more (manager start date not on record)
Risk and reward—
  • – Sharpe ratio is at or above the category median
  • – Sortino ratio is at or above the category median
  • – Volatility is at or below the category median
  • – Worst 3-year fall is no deeper than the category median
  • – Jensen's alpha is positive

Risk and return ratios 3-year window

Risk-free rate 6.06% (3-year annualised return of the NSE 1-day (overnight) rate index). This category has no reference index in our data, so benchmark-relative ratios are not shown.

RatioThis fundCategory medianAgainst category
Sharpe ratio — 0.46 —
Sortino ratio — 0.65 —
Standard deviation — 13.27% —
Maximum drawdown — -15.52% —
Beta — 1.00 —
R-squared — 100.0% —
Jensen's alpha — -0.41% —
Treynor ratio — 2.09 —
Information ratio — -3.62 —
Upside capture — 99.6% —
Downside capture — 100.0% —

SIP returns (monthly instalments, XIRR)

1 year
+20.50%
3 years
—
5 years
—

What if you had invested?

Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.

Portfolio as of 31 Aug 2026

Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. The feed carries weights only: no quantities or rupee values.

Holdings
126
Top 5 / top 10
35.2% / 54.6%
Largest holding
12.9%
Mapped to Tradinity companies
99%
Portfolio P/E
57.1
category median 31.1
Portfolio ROE
14.3%
category median 18.0%
Portfolio dividend yield
0.54%
category median 1.58%
Largest sector
—

Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.

Holdings

Export CSV
HoldingSectorWeight3M changeP/E
Sun Pharmaceutical Industries Limited Healthcare 12.95% — 146.5
Divi's Laboratories Limited Healthcare 7.22% — 83.9
Apollo Hospitals Enterprise Limited Healthcare 5.55% — 74.7
Cipla Limited Healthcare 4.91% — 35.4
Max Healthcare Institute Limited Healthcare 4.62% — 126.0
Laurus Labs Limited Healthcare 4.48% — 122.5
Torrent Pharmaceuticals Limited Healthcare 4.36% — 78.2
Dr. Reddy's Laboratories Limited Healthcare 4.35% — 154.7
Lupin Limited Healthcare 3.24% — 13.3
Fortis Healthcare Limited Healthcare 2.90% — 257.5
Aurobindo Pharma Limited Healthcare 2.89% — 37.4
Glenmark Pharmaceuticals Limited Healthcare 2.28% — 321.6
Alkem Laboratories Limited Healthcare 1.92% — 28.9
Zydus Lifesciences Limited Healthcare 1.79% — 33.3
Biocon Limited Healthcare 1.77% — 597.3
IPCA Laboratories Limited Healthcare 1.69% — 39.3
Mankind Pharma Limited Healthcare 1.64% — 47.4
Gland Pharma Limited Healthcare 1.40% — 34.3
Aster DM Quality Care Limited Healthcare 1.22% — 207.5
Neuland Laboratories Limited Healthcare 1.21% — 55.1
Sai Life Sciences Limited Healthcare 1.21% — 90.6
Krishna Institute Of Medical Sciences Limited Healthcare 1.15% — 111.2
Acutaas Chemicals Limited Healthcare 1.00% — 67.6
Wockhardt Limited Healthcare 0.96% — 96.6
Ajanta Pharma Limited Healthcare 0.94% — 44.9
Dr. Lal Path Labs Limited Healthcare 0.92% — 38.7
Piramal Pharma Limited Healthcare 0.82% — 39.2
Abbott India Limited Healthcare 0.81% — 35.7
Narayana Hrudayalaya Limited Healthcare 0.81% — 64.4
Global Health Limited Healthcare 0.78% — 76.2
Anthem Biosciences Limited Healthcare 0.77% — 77.2
GlaxoSmithKline Pharmaceuticals Limited Healthcare 0.76% — 44.3
Granules India Limited Healthcare 0.73% — 51.3
Onesource Specialty Pharma Limited Healthcare 0.72% — 366.7
Shilpa Medicare Limited Healthcare 0.68% — 111.8
Triparty Repo TRP_010926 — 0.61% — —
Eris Lifesciences Limited Healthcare 0.49% — 84.7
Natco Pharma Limited Healthcare 0.47% — 16.6
Syngene International Limited Healthcare 0.47% — 64.2
Cohance Lifesciences Limited Healthcare 0.45% — 95.7
Vijaya Diagnostic Centre Limited Healthcare 0.45% — 76.7
Rainbow Childrens Medicare Limited Healthcare 0.44% — 53.1
Jubilant Pharmova Limited Healthcare 0.43% — 709.5
Pfizer Limited Healthcare 0.43% — 24.1
Marksans Pharma Limited Healthcare 0.42% — 45.5
Strides Pharma Science Limited Healthcare 0.42% — 42.5
Poly Medicure Limited Healthcare 0.41% — 50.5
Emcure Pharmaceuticals Limited Healthcare 0.39% — 45.5
Indegene Limited Healthcare 0.39% — 62.6
Metropolis Healthcare Limited Healthcare 0.38% — 27.5
Rubicon Research Limited Healthcare 0.35% — 111.8
Jupiter Life Line Hospitals Limited Healthcare 0.34% — 9.0
Caplin Point Laboratories Limited Healthcare 0.31% — 47.9
Concord Biotech Limited Healthcare 0.30% — 51.0
Alembic Pharmaceuticals Limited Healthcare 0.28% — 22.1
Procter & Gamble Health Limited Healthcare 0.28% — 25.9
Aarti Pharmalabs Limited Healthcare 0.27% — 41.5
AstraZeneca Pharma India Limited Healthcare 0.27% — 91.2
Alivus Life Sciences Limited Healthcare 0.26% — 28.1
Yatharth Hospital And Trauma Care Services Limited Healthcare 0.26% — 103.1
Bliss GVS Pharma Limited Healthcare 0.25% — 64.2
Viyash Scientific Limited Healthcare 0.25% — 166.1
Dr Agarwals Health Care Limited Healthcare 0.24% — 330.6
Healthcare Global Enterprises Limited Healthcare 0.24% — 569.3
Morepen Laboratories Limited Healthcare 0.23% — 61.5
Thyrocare Technologies Limited Healthcare 0.23% — 34.1
Senores Pharmaceuticals Limited Healthcare 0.22% — 254.7
Suven Life Sciences Limited Healthcare 0.18% — —
Kovai Medical Center and Hospital Limited Healthcare 0.17% — 25.6
Sanofi Consumer Healthcare India Limited Healthcare 0.17% — 32.9
Sanofi India Limited Healthcare 0.17% — 21.7
Akums Drugs and Pharmaceuticals Limited Healthcare 0.16% — 112.3
IOL Chemicals and Pharmaceuticals Limited Healthcare 0.14% — 36.1
Supriya Lifescience Limited Healthcare 0.13% — 38.5
Blue Jet Healthcare Ltd Healthcare 0.12% — 39.7
Sun Pharma Advanced Research Company Limited Healthcare 0.12% — 4.0
Innova Captab Limited Healthcare 0.11% — 69.5
Artemis Medicare Services Limited Healthcare 0.10% — 48.3
FDC Limited Healthcare 0.10% — 18.7
Indraprastha Medical Corporation Limited Healthcare 0.10% — 17.0
Park Medi World Limited Healthcare 0.10% — —
Aarti Drugs Limited Healthcare 0.09% — 22.9
Kwality Pharmaceuticals Limited Healthcare 0.09% — 46.6
Nephrocare Health Services Ltd Healthcare 0.09% — —
Orchid Pharma Limited Healthcare 0.09% — 148.1
Solara Active Pharma Sciences Limited Healthcare 0.09% — —
Advanced Enzyme Technologies Limited Healthcare 0.08% — 39.3
Corona Remedies Limited Healthcare 0.08% — 64.5
Gujarat Themis Biosyn Limited Healthcare 0.08% — 86.7
Dishman Carbogen Amcis Limited Healthcare 0.07% — —
Gufic Biosciences Limited Healthcare 0.07% — 58.9
Novartis India Limited Healthcare 0.07% — 48.4
RPG Life Sciences Limited Healthcare 0.07% — 42.0
SMS Pharmaceuticals Limited Healthcare 0.07% — 47.9
Unichem Laboratories Limited Healthcare 0.07% — 23.1
Indoco Remedies Limited Healthcare 0.06% — 23.1
Krsnaa Diagnostics Limited Healthcare 0.06% — 18.4
Syncom Formulations India Limited Healthcare 0.06% — 27.0
Vimta Labs Limited Healthcare 0.06% — 33.6
Fischer Medical Ventures Limited Healthcare 0.05% — —
Hester Biosciences Limited Healthcare 0.05% — 31.4
Hikal Limited Healthcare 0.05% — —
Sigachi Industries Limited Healthcare 0.05% — 41.7
Windlas Biotech Limited Healthcare 0.05% — 34.5
3B BlackBio Dx Limited Healthcare 0.04% — 28.8
Dr.Agarwals Eye Hospital Limited Healthcare 0.04% — 32.3
Kopran Limited Healthcare 0.04% — 40.0
Lincoln Pharmaceuticals Limited Healthcare 0.04% — 12.2
Panacea Biotec Limited Healthcare 0.04% — —
Suraksha Diagnostic Limited Healthcare 0.04% — 50.3
Fermenta Biotech Limited Healthcare 0.03% — 25.2
GPT Healthcare Limited Healthcare 0.03% — 26.2
Jagsonpal Pharmaceuticals Limited Healthcare 0.03% — 35.0
KMC Speciality Hospitals (India) Limited Healthcare 0.03% — 50.0
Shalby Limited Healthcare 0.03% — 13.3
Tarsons Products Limited Healthcare 0.03% — 86.1
Wanbury Limited Healthcare 0.03% — 11.5
Bajaj Healthcare Limited Healthcare 0.02% — 46.1
Gujarat Kidney And Super Speciality Limited Healthcare 0.02% — 133.6
Laxmi Dental Limited Healthcare 0.02% — 59.4
Themis Medicare Limited Healthcare 0.02% — 35.8
Anuh Pharma Limited Healthcare 0.01% — 19.8
Fabtech Technologies Limited Healthcare 0.01% — 14.5
Health X Platform Limited Healthcare 0.01% — —
Nectar Lifesciences Limited Healthcare 0.01% — 22.3
Shree Ganesh Remedies Limited Healthcare 0.01% — 57.2

This is a paid feature

Comparing more months of this fund's own portfolio history is available on paid plans.

Sign in

Fund details

Fund houseBandhan Mutual Fund
AMFI scheme code152844
CategoryIndex Funds › Index Funds
AMFI categoryOpen Ended Schemes(Other Scheme - Index Funds)
Plan / optionDirect / Growth
ISININF194KB1IS2
NAV history from9 Sep 2024
NAV points on record515

Cost and size

Expense ratio (direct, Sep 2026)
0.36%
category median 0.36%
Assets under management
₹10 crore
average, June-2026
Regular plan expense ratio
1.16%

Expense ratio by month: Oct 25 0.22% · Nov 25 0.22% · Dec 25 0.22% · Jan 26 0.22% · Feb 26 0.23% · Mar 26 0.23% · Apr 26 0.22% · May 26 0.22% · Jun 26 0.33% · Jul 26 0.31% · Aug 26 0.32% · Sep 26 0.36%

From the scheme information document

Benchmark
BSE Healthcare TRI
SEBI riskometer
Very High
Registrar
Computer Age Management Services Pvt. Ltd.(CAMS)
Minimum investment
Rs.1000
Minimum additional
Rs.1000
SIP
SIP- Rs.100, STP- Rs.500, SWP- Rs.200.
Fund manager(s)
FM 1 - Mr. Abhishek Jain, FM 2 - Mr. Mayuresh Nagvekar

Exit load

• 0.25% - if redeemed on or before 15 days from the allotment date.; • Nil – if redeemed after 15 days from the allotment date

Objective

The investment objective of the Scheme is to replicate the BSE Healthcare Index by investing in the underlying securities in the same proportion, subject to tracking error. The BSE Healthcare Index will track the performance of companiesthat are part of BSE AllCap belonging to the Healthcare sector.

Scheme information document

Fund house: website · factsheets · monthly portfolio · annual report

Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.

Other plans of this fund

Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.